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ABSTRACT

Annu Kavya, M.S. Department of Pharmacology and Toxicology, Wright State
University, 2015. The Role of NKCC2A co-transporter in the nervous system activity.

The NKCC2A is a splice variant of the Na+K+2Cl- co-transporter 2 (Slc12a1), which
is abundantly expressed in macula densa and in the apical membrane of the tubular
cells in the kidney. Most of our knowledge regarding NKCC2 function is limited to
the kidney, the organ where NKCC2 is abundantly expressed. However, recent studies
have demonstrated that NKCC2 is also expressed in extra-renal tissues. This study
was designed to determine if NKCC2A, a splice variant of NKCC2 has an impact on
behavior and nervous system activity of mice. To these ends, we used mice (wild
type, WT), lacking a single or both alleles of NKCC2A (heterozygous, HE and
homozygous, HO, respectively) which were subjected to battery of standardized
behavioral tests. NKCC2A-HO mice exhibited a significant gating impairment when
compared to the WT or HE genotypes. Interestingly, NKCC2A-HO mice also
exhibited a significantly lower immobility time compared to the WT and HE mice in
the forced swim test (FST), a finding that could not be reproduced in the tail
suspension test (TST). Nevertheless, the caudate nucleus of NKCC2A-HO mice
exhibited low content of serotonin (5-HT) and dopamine metabolites, which might
account for the reduced immobility time assayed by the FST. NKCC2A-HO mice had
significantly lower levels of epinephrine (EPI) and norepinephrine (NE) in the
adrenals, with the HE mice having intermediate levels suggesting a role of NKCC2A
iii

in sympathetic activity, a conclusion suggested by the finding that these mice excreted
low urinary EPI and NE. Together, the results of this study indicate that NKCC2A
impacts behavior and neurochemistry in specific regions of the brain and the
periphery.
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1. Introduction
1.1 SLC12A Gene family
The electroneutral inorganic cation-chloride co-transporters (CCCs) belong to the
solute carrier 12 gene family (SLC12) which consist of nine homologous members:
SLC12A1-9. They play several important roles in human physiology, including cell
volume regulation, hydro electrolytic balance, fluid secretion, neurotransmission and
hormone secretion. This family of genes encode plasma membrane proteins that
mediate the movement of inorganic sodium (Na+) and/or potassium (K+) cations
coupled to the movement of chloride (Cl-) anions. For instance, the SLC12A1 and
SLC12A2 genes encode Na-dependent K-Cl co-transporters widely known as
NKCCs, whereas SLC12A3 encode several Na-Cl co-transporters. These proteins
upload Cl- into the cells by using the thermodynamic energy produced by the inward
movement of Na+ (Gagnon and Delpire. 2013). All members of the SLC12A family
are structurally closely related but differ in functional properties, transcriptional
regulation and post-transcriptional modulation of activity which may contribute to
their relative role in different functions (Hubner et al. 2001).

1.2 NKCC1
The SLC12A2 gene encodes the Na+/K+/2Cl- co-transporters-1 (NKCC1) which are
ubiquitous and secretory in nature (Gamba et al. 1994). Multiple studies on NKCC1
knock out mice confirmed that it is not essential for the survival. Head bobbing and
circling behavior is the most confounding phenotype of NKCC1 knockout mice
(Delpire et al. 1999). They had defects in hearing and balance suggesting both
cochlear and vestibular defects (Gagnon and Delpire. 2013; Hubner et al. 2001).
NKCC1 was found to be involved in a variety of adult organ functions including the
1

central nervous system (CNS). Active Cl- accumulation via NKCC1 activated the
GABAA receptor mediated depolarization in immature neurons (Clayton et al. 1998).
As the neurons mature, the intracellular Cl- concentration decreases which result in a
shift towards GABAA–mediated inhibition. It was also shown that GABA was
excitatory in arginine vasopressin (AVP) neurons which are located in the
paraventricular nucleus of the hypothalamus that produce and release oxytocin and
vasopressin into the blood circulation and so, this effect was increased by chronic
hyperosmotic stress of salt loading. In this study, these effects were attributed to
NKCC1. However, NKCC2 may also be important in this regard. Indeed, it has been
recently demonstrated that NKCC2 is expressed in AVP neurons and that its
expression is increased in response to chronic dehydration (Konopacka et al. 2015).

Figure 1 - Diagrammatic representation of NKCC2 functional role in the kidney
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1.3 NKCC2
The SLC12A1 gene encodes several Na+/K+/2Cl- co-transporters-2 (NKCC2) which
are expressed in the apical membrane of the tubular cells of the thick ascending limb
(TAL) of Henle and in the macula densa (Gamba et al. 1994; Gagnon and Delpire.
2013; Hubner et al. 2001). NKCC2s are considered absorptive isoforms of the
NKCCs. They are responsible for 25-30% of body’s total renal salt retrieval and
therefore, they participate in the concentration capacity of the kidney (Castagné et al.
2001). Indeed, approximately 80% of the NaCl uptake across the apical membrane of
the TAL cells is mediated by NKCC2 (Castrop and Schnermann. 2008). NKCC2s as
well as NKCC1 are sensitive to furosemide and bumetanide the most commonly
prescribed diuretics. Inactivating mutations in the SLC12A1 gene cause Bartter’s
syndrome type 1, an autosomal recessive salt-wasting disorder characterized by
polyuria, renal tubular hypokalemic alkalosis, and hypercalciuria (Simon et al. 1996;
Gagnon and Delpire. 2013).

1.4 NKCC2 Isoforms
The SLC12A2 gene produce at least three variants named NKCC2A, NKCC2B and
NKCC2F. They are the result of alternative selection of three mutually exclusive
exons (Gamba et al. 1994; Carota et al., 2010; Payne and Forbush, 1994; VargasPoussou et al., 1998). These isoforms differ in their localization and transport
characteristics along the TAL. The renal localization of the NKCC2 isoforms follows
a general pattern despite a few interspecies differences. They are found in the apical
membrane and in subapical vesicles along the TAL and in the macula densa segment.
NKCC2A is expressed in the outer stripe of the outer medulla and in the cortical
portions of the TAL in rodents (Oppermann et al., 2006; Oppermann et al., 2007).
NKCC2A is the dominant isoform in the human cells and is found along the entire
3

kidney.
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NKCC2F>>NKCC2A>NKCC2B (Castrop and Schnermann. 2008).

1.5 NKCC2A
NKCC2A exhibits a markedly higher Cl⁻ affinity than NKCC2F whereas NKCC2B
has highest Cl⁻ affinity but lower transport capacity (Plata, Meade, Vazquez, Hebert,
and Gamba, 2002). At low tubular Cl⁻ concentrations, Cl⁻ reabsorption was
significantly reduced in NKCC2B-deficient mice when compared to WT mice,
whereas no differences were observed for NKCC2A-HO mice (Oppermann et al.,
2007). However, the lack of NKCC2A in mice resulted in reduced Cl⁻ absorption at
high Cl⁻ concentrations. Under low Cl⁻ load, TAL reabsorption becomes dependent
on the activity of the high- Cl⁻-affinity NKCC2B isoform. Conversely, absence of
NKCC2A function becomes obvious in mice subjected to a high load of NaCl
including that high tubular Cl⁻ concentrations modulate the transport activity
NKCC2A. This suggests that NKCC2A transport activity exceeds that of NKCC2B,
which might be related to both the higher transport capacity of NKCC2A essentially
and its higher expression levels (Castrop and Schnermann, 2008).

1.6 Expression and role of NKCC2 in extra-renal tissues
NKCC2 has been typically regarded as a kidney-specific ion transporter. However,
recent findings suggest that it is also expressed in the endolymphatic sac (ES)
epithelium (Nishimura, Kakigi, Takeda, Takeda, and Doi, 2009). There was also
evidence for NKCC2 mRNA transcripts, and protein expression in the rat
gastrointestinal tract (Xue et al. 2009). In fact, NKCC2 appears to be widely
distributed and expressed in the enteric neurons in the myenteric plexus and it is
4

considered to play a role in the ion transport and neuronal excitability in the gut. Its
expression in other nerve tissues has never been reported previously but there is a
recent study showing the expression of NKCC2 in the brain hypothalamoneurohypophyseal system (HNS), in particular the supraoptic and paraventricular
nuclei (Konopacka et al. 2015). HNS is a specialized brain region which contain the
neurons that produce peptide hormones, arginine vasopressin (AVP) and oxytocin
(OXT). AVP modulates the ability of the kidney to retain water free of solutes
whereas OXT has an important role in sexual reproduction, social behavior, lactation
or parturition (Konopacka et al. 2015).
The hypothalamus is a fundamental structure involved in the integration of the
nervous and endocrine systems, and a key regulator in the whole body homeostasis
including glucose homeostasis (Lam et al. 2009). Although the impact of NKCC2 in
glucose homeostasis remains undefined, a potential role of NKCC2 in insulin
secretion has been suggested. Indeed, NKCC1 and NKCC2 are co-expressed in
insulin-secreting beta-cells (Alshahrani and Di Fulvio. 2012a; Alshahrani and Di
Fulvio. 2012b) and elimination of NKCC1 does not preclude secretion of the hormone
in response to bumetanide.
If a mutation or deletion of a gene is thought to modify a physiological response or a
single function, there could be other unexpected alterations in the whole animal.
However, this reasoning cannot exclude the possibility that the gene of interest may
produce its proteins in previously undescribed locations exhibiting different functions.
This may be the case of mice lacking a single variant of NKCC2, where its “kidneyspecific” location and very well-known function cannot represent its potential
function in extra-renal tissues including brain, where our preliminary data suggested
NKCC2 expression (unpublished data) and a recent report confirmed (Konopacka et
5

al. 2015). The influence of a given gene on a specific behavior can be evaluated by
conducting behavioral studies in mice lacking expression of such gene (Komada et al.
2008). NKCC1 knockout mice had behavioral alterations relating this effects to its
presence in the central and peripheral neurons. So, a quick way to evaluate neural
functions and activity alterations is behavior. Behavioral effects reflect the changes in
nerve cell communication and integration as well as morphological alterations (Kulig
et al. 1996). Our preliminary studies indicating presence of NKCC2 in some brain
areas which lead us to investigate effects of deletion of NKCC2A in the mice.

1.7 Behavior
The work of the present thesis sprouted upon casual noticing of uncommon behavior
in mice with functional deficiency in a single or in both alleles of the SLC12A1 gene.
As mentioned, this gene is responsible for one of the three main splice variants of the
Na+/K+/2Cl- co-transporter-2 (NKCC2), named NKCC2A. These observations were
originally made in the laboratory of Dr. Mauricio Di Fulvio and included: unusual
aggressiveness and defensive postures toward the corner of cages, absence of
withdrawal reflexes, head bobbing, seizure-like behavior or abnormal weight gain in
some but not all of these mice. Hence, a battery of standardized behavioral tests was
requested and thoroughly conducted by Teresa Garrett in the laboratory of Dr. James
Lucot in the Department of Pharmacology and Toxicology at Wright State University,
Boonshoft School of Medicine.
Several tests to analyze behavior in mice have been developed. Some of them are
more specific than others and represent the functional interaction of particular regions
within the brain. Several of these tests are summarized in Table 1.
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Table 1 - Summary of Behavioral tests

Behavioral test
Functional

Implicated brain regions

operational CNS

To assess and quantify the behavioral and

battery (FOB)
Open field test (OFT)

Elevated plus maze (EPM)

Use

physiologic state of the mouse
Amygdala

To assess locomotor activity and anxiety in

Hippocampus

rodents

Amygdala

To assess anxiety in rodents

Right prefrontal cortex
Y maze test

Hippocampus

To assess exploratory activity

Prepulse inhibition (PPI)

Pons

Measure of sensory motor gating

Prefrontal cortex
Forebrain
Rotarod

Cerebellum

To evaluate motor coordination and balance

Forced swim test (FST)

Rostral anterior cingulate

To evaluate anti-depressant-like effect

cortex (amygdala, nucleus
accumbens, hypothalamus
Tail suspension test (TST)

Anterior cingulate cortex

To evaluate anti-depressant-like effects

(prefrontal cortex, amygdala,
nucleus accumbens,
hypothalamus)

Visually observed deficits in the gait of NKCC2A-HO mice led us to design
experiments to evaluate the behavioral abnormalities of this animal model according
to the established tests (Table1). Their unusual overall aggressiveness (unpublished
observation) suggests there might be increased sympathetic activity which can be
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evaluated by testing urinary catecholamines or by analyzing changes in urine
catecholamine output rate.
The behavior of mice is usually assessed by subjecting them to a battery of
standardized tests. Collectively known as the functional observational battery (FOB),
this systematic observational method is applied to comprehensively assess and
quantify the behavioral and physiologic state of the mouse. For instance, locomotor
activity and thigmotactic (tolerance to less stressful environment) behavior of mice
can be assessed by using the Open field test (OFT) (Castagné, Moser, Roux, and
Porsolt, 2001). It can also be used as a surrogate to assess anxiety in rodents. The
elevated plus maze (EPM), however, exploits the natural aversion of mice for open
and elevated areas, as well as on their normal exploratory behavior towards novel
environments (Komada et al. 2008). The EPM is sensitive to anxiolytic effects in
neurotoxic lesions of serotonergic neurons and other effects caused by anxiolytic
drugs. The prepulse inhibition of startle (PPI) test is an operational measure of
sensory gating, usually disrupted in schizophrenia and some other mental disorders
and neurodegenerative diseases. The rotarod test is used to evaluate motor
coordination and balance. It assesses the animal’s ability to maintain balance and
walk on a rotating rod. The forced swim test (FST) is a rodent behavioral test used for
evaluation of the antidepressant efficacy of new compounds and experimental
manipulations that are aimed at generating or preventing depressive-like states
(Castagné et al. 2001). The tail suspension test (TST) is used to screen potential
antidepressant drugs, and to assess other manipulations expected to affect depressionrelated behaviors (50 Can, Adem 2012).
Forced swimming or exposure to high intensity acoustic stimuli or any other stress
activates the hypothalamo-pituitary axis and has an anxiogenic effect on behavior.
8

This activation is dependent on hypothalamic centers including the paraventricular
and supraoptic nuclei and the release of hormones which regulate the secretion of
adrenocorticotropic hormone from the pituitary as well as sympatho-adrenal outflow.
Stressors that disturb physiological homeostasis activates pituitary-adrenal and
sympatho-adrenal axis via extended amygdala inputs to the hypothalamus and brain
stem, and exert anxiogenic-like behavioral consequences via actions on a variety of
mid and forebrain nuclei. Therefore, changes in the mice behavior as analyzed by
using FOB may indicate a disturbance in the physiological homeostasis and involves
many brain areas such as the amygdala, hypothalamus, brain stem, mid and forebrain.

1.8 Neuronal systems
The neuronal systems involved in the mice behavior can be evaluated by measuring
the neurotransmitter concentrations while correlating them to a particular behavior
change. As many major theories suggest, neurobehavioral disorders may result from
changes in the dopamine (DA) usage in specific brain areas such as frontal cortex,
caudate, brain stem, nucleus accumbens, and hypothalamus (Howes and Kapur. 2009;
Mehler-Wex et al. 2006). Therefore these mouse brain areas are usually selected to
analyze changes in DA or the turnover of the neurotransmitter serotonin/5hydroxytryptamine (5-HT).

9

Figure 2 - Dopaminergic cell bodies (A8, A9, and A10) projects to the ventral
tegmental area (VTA), substantia nigra (SNc) and the retrorubral field (RRF).

The dopaminergic and noradrenergic cell groups are designated with letter A, where
A8-A15 are dopaminergic groups. The serotonergic cell groups are designated with
letter B and adrenergic with letter C. Fig 2 illustrates different dopaminergic cell
groups such as olfactory bulb (OB) dentritic periglomerular (A16) neurons, the
hypothalamic (Hyp; A12, A14 and A15) cell groups. Among this A12 provides
10

tuberoinfundibular and tuberohypophysial projections involved in the neuroendocrine
regulation. A8-A10 are the mesodiencephalic tegmental cell groups comprising SNc
(A9 neurons), the VTA (A10 neurons) and the retrorubral fields (RRF; A8 neurons).
Brain areas receive DA neuronal projections from distinct dopamine pathways which
have different physiological and pathophysiological significance e.g. mesolimbicmesocortical and nigrostriatal projections (Fuxe et al. 1974; Inglis and Moghaddam.
1999; Oades and Halliday. 1987; Feldman. 1997). Figure 2 illustrates different DA
neuron bodies as mentioned above.
Ventral tegmental area (VTA; A10 cell groups) is the origin for the dopaminergic cell
bodies of mesocortical system and mainly innervated frontal cortex of the brain (Fuxe
et al. 1974; Oades and Halliday. 1987; Feldman. 1997). It is mainly involved in
cognition and behavior. It contains neurons projecting from prefrontal cortex to the
caudate and brain stem (Bjorklund et al. 1975; Bjorklund and Dunnett. 2007).
In the nigrostriatal pathway, as illustrated in figures 2 and 3, dopaminergic pathways
run from the zona compacta of the substantia nigra (A9), and nigrostriatal fibers
which produce very dense innervation project into the caudate nucleus, putamen and
the globus pallidus (Fig 3). It is especially involved in the production of movement
which is a part of basal ganglia motor loop. Loss of dopamine neurons in this pathway
is implicated in several disorders like Parkinson’s disease, tardiv dyskinesia (Fahn and
Mayeux. 1980; Feldman. 1997).
In the mesolimbic pathway, the dopamine is transmitted from the VTA (A10) to the
limbic system along nucleus accumbens. Mesolimbic and nigrostriatal dopamine
axons arising from midbrain nuclear groups retrorubral nucleus (A8), substantia nigra
(A9) and VTA (A10) forms a bundle lateral to hypothalamus and projects into
11

amygdala, hippocampus and some brain regions of the medial prefrontal cortex
(Feldman. 1997, Bjorklund and Dunnett. 2007). Different brain regions receiving
dopaminergic neurons are involved in different functions.
The amygdala, a component of mesolimbic DA system, participates in conditioned
fear (Fadok et al. 2009). Hippocampus is a primary component of the mesolimbic
dopaminergic system involved in cognitive functions and dopaminergic projections to
the hypothalamus regulates neuroendocrine functions (Bjorklund et al. 1975).
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Figure 3 – Dopamine pathways in the brain

5-HT is also a monoamine neurotransmitter with an important role in the regulation of
sleep, mood, appetite and cognitive functions. 5-HT pathways are named from B1-B9
where B1, B2, and B3 are called the caudal group and as illustrated in figure 3, caudal
group gives rise to descending pathways into the dorsal, intermediate and ventral
horns of the spinal cord. B4-B9 makes up the ascending 5-HT pathways where B5
13

and B6 pathways innervate the limbic structures, especially from raphe medianus,
hypothalamus and the preoptic area. B7, B8 and B9 gives rise to lateral pathway
which innervates cingulate cortex. There is another pathway that originates from B7B9 and primarily innervates the extrapyramidal motor pathways which arise from the
caudate nucleus. The cerebellum is also innervated by 5-HT. Very fine 5-HT neurons
were observed in septum, hippocampus and into the neo- and mesocortex (Figure 4:
Feldman. 1997).

Figure 4 - 5-HT pathways in the brain
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1.9 Brain – monoamines
Behavioral deficits are usually correlated with neurochemical changes in specific
regions of the brain. The monoamine neurotransmitters norepinephrine (NE),
dopamine (DA), and serotonin (5-HT) are important to normal functioning of the
brain and periphery. Current theories of the basis for major neurobehavioral disorders
involve abnormalities in the use/metabolism of NE, 5-HT and DA in specific brain
regions. To correlate potential changes in these monoamines with observed behavior,
the concentration of NE, DA and their metabolites homovanillic acid (HVA) and
dihydroxyphenylacetic acid (DOPAC) as well as, 5-HT and its metabolite 5hydroxyindole acetic acid (5-HIAA) are usually measured in the frontal cortex,
amygdala, hippocampus, hypothalamus, brainstem, accumbens, caudate and
hypothalamus by using reverse phase high performance liquid chromatography.

1.10 Role and Metabolism of DA and 5-HT
DA is the precursor to norepinephrine (NE) and epinephrine (EPI). Apart from this, it
has many other important functions in the brain.
Dopaminergic neurotransmission in different brain regions such as the frontal cortex
(FC), amygdala and the caudate plays an essential role in cognition, attention,
motivation and reward, learning, creativity and motor activity. Catechol-Omethyltransferase (COMT) and monoamine oxidase (MAO) metabolizes DA to HVA
and DOPAC. These are the most significant DA metabolites. The neurotransmitter
rate of usage can be determined from the ratio of the metabolite to the parent
compound e.g. HVA/DA or DOPAC/DA. HVA is the extra-neuronal (metabolized
outside the neurons) metabolite whereas DOPAC is the intra-neuronal (metabolized in
the neurons) metabolite of DA (Figure 5: (Feldman. 1997)).

15

Figure 5 - DA metabolism in the dopaminergic nerve terminal and synapse.
In addition to nervous tissue, adrenal glands produce a NE and E as sympathetic
nervous system transmitters. Thus to further extend behavioral studies, it is
convenient to determine the levels of these catecholamines in adrenal glands as well
as in the kidney, the major organ involved in excretion.

1.11 Kidney Dopaminergic Systems
The kidney’s intrarenal dopaminergic system is distinct from other neural
dopaminergic input. Dopamine acts as an intrarenal natriuretic hormone (Jose et al.
1992). Kidney dopamine levels can reach high nano molar concentrations whereas
circulating dopamine levels are in the pico molar range (Zeng and Jose, 2011). The
dopamine precursor L-DOPA (L-dihydroxyphenylalanine) is taken up from the
circulation by the proximal tubule or through filtration via the glomerulus. It is then
converted to dopamine by aromatic amino acid decarboxylase. This dopamine
produced in the proximal tubule serves as an autocrine/paracrine agent that inhibits
16

the Na+/K+-ATPase activity in the medullary TAL and in the cortical collecting duct
mediated by D1 receptors. Renal proximal tubules produce dopamine which serves as
an intrarenal natriuretic factor by direct tubular action independent of hemodynamic
mechanisms. Approximately 60% of the sodium excretion is mediated by D1
receptors which in turn is mediated by increased renal dopamine production and
increased sensitivity of sodium transporters to dopaminergic inhibition.

1.12 NKCC2 and Dopamine in the Kidney
In the kidney, 25-30% of the body’s total renal salt retrieval is through the
reabsorption of NaCl in the TAL, a phenomenon mediated by NKCC2. Dietary salt
modulates intrarenal dopamine production (Nishimura et al., 2009). In the mammalian
kidney, dopamine receptor activation due to increased dopamine release decreases
NaCl and water reabsorption through inhibition of specific tubule transporter activity
along the nephron including the Na+/K+-ATPase in the proximal tubule, and NKCC2
in the TAL (Corrigenda for vol. 283, p. F221.2003; Bacic et al., 2005; Grider, 2003).
Therefore, dopamine receptor activation indirectly inhibits Na/K-ATPase and NKCC2
function. This is due to increased renal dopamine release and increased sensitivity of
sodium transporters to dopaminergic inhibition. Therefore, absence of NKCC2A in
mice might impact dopamine utilization and this can be tested by analyzing dopamine
concentrations in the urine samples.
In the TAL, NaCl reabsorption is stimulated by vasopressin, parathyroid, glucagon,
epinephrine and norepinephrine. This mechanism is mediated, either directly or
indirectly, by altering NKCC2 activity. Sodium transport via NKCC2A or NKCC2B
at the macula densa initiates the tuberoglomerular feedback mechanism. Dopamine in
the kidney is known to stimulate NKCC2 activity, but controversially, dopamine
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inhibits the tubuloglomerular pathway. Interestingly NKCC2A-HO mice exhibited
decreased maximum tubuloglomerular feedback responses (Oppermann et al. 2007).
Therefore, this study is designed to determine the effect of NKCC2A on the E, NE
and DA levels in the urine a reflex of the basal sympathetic activity of the animal.

2. Development of Hypothesis
The hypothesis is that elimination of NKCC2A in vivo alters behavior and in
neurochemical usage in the central and peripheral nervous systems.
NKCC2A has different level of expression in WT, HE and HO mice tissues. HE mice
have NKCC2A expression intermediate to HO and WT. WT had much higher
expression than HE whereas the HO did not have any expression (unpublished data).
Therefore, to find the effect of NKCC2A, we have included HE mice group along
with WT and HO in our studies.

2.1 Specific Aims
Aim 1 To test the hypothesis that NKCC2A-HO mice have neurobehavioral deficits.
NKCC2A-HO mice were used as a model to evaluate the behavioral phenotypes.
NKCC2A-HO, HE and WT mice were screened for gross functional deficits,
locomotion, psychosis, working memory, anxiety, and depression.
Aim 2 To test the hypothesis that NKCC2A-HO mice have altered DA, 5-HT metabolism
and changes is NE levels in selective brain regions.
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Brain regions such as frontal cortex, amygdala, hippocampus, brainstem, accumbens,
caudate and hypothalamus were evaluated for DA, 5-HT usage. Reverse-phase high
performance liquid chromatography (RP-HPLC) was used to measure concentrations
of NE, DA and its metabolites DOPAC and HVA, 5-HT and its metabolite 5-HIAA in
selected brain regions with DA and 5-HT neuronal projections.
Aim 3 To evaluate the impact of NKCC2A-HO on kidney DA levels as well as on basal
sympathetic activity by measuring urinary DA, NE and EPI.
Aim 4 To test the hypothesis that NKCC2A-HO might show changes in total NE and EPI in
the adrenal glands. HPLC was used to measure them in the adrenal glands.
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3. Experimental Design

Figure 6 - Experimental design
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4. Materials and Methods
4.1 Animals
Mice subjected to behavioral studies were generated from mice lacking a single
functional allele of NKCC2A (heterozygous) kindly provided by Dr. Hayo Castrop
(University of Regensburg) to Dr. Di Fulvio. Mice were used according to approved
animal protocols and the material transfer agreement signed by both parties. Mice
were used at the age of 8 weeks and both female and male mice were used in all
experiments.

4.2 NKCC2A-HO mice generation
NKCC2A-HO mice were generated by Dr. Hayo Castrop at the University of
Regensburg and all the procedures were approved by the Animal Use and Care
Committee of the National Institute of Diabetes and Digestive and Kidney Diseases
and by the Animal Care Committee of the University of Regensburg. NKCC2A-HO
mice were generated according to a similar strategy which was used to generate
NKCC2B-HO mice earlier (Oppermann et al. 2006). They were generated by altering
the exon 4A of the SLC12A1 gene by the introduction of in-frame stop codons which
result in the premature termination of the translation. Homologous arms were
generated by long-distance PCR (Roche, Indianapolis, IN). Progeny lacking the neo
gene was intercrossed to generate NKCC2A-HO, HE and WT littermates (Oppermann
et al. 2007).

4.3 NKCC2A-HO, HE and WT genetic analysis
To identify WT, HE or HO mice, we took advantage of the genetic strategy followed
to create these mice to design primer sets for genotyping. We used the polymerase
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chain reaction (PCR) to determine them. The genotyping primers recognizing
flanking intronic sequences 5’ and 3’ exon A were: 5’-TGC AGG AGT GGG TAG
TCC AA-3’ AND 5’-CCG TAG CAT GTG ACG TGG AT-3’. This primer set
amplifies a single DNA fragment of 206 bp or 302 bp from genomic DNA obtained
from WT or HO mice, respectively, to the two fragments simultaneously in the case
of HE mice. The procedure for genotyping mice was developed and set up in our
laboratory by Victor Otano-Rivera (Undergraduate STREAMS student) and Amma
Boayke (Undergraduate HONORS student) and was based on the original protocol
written by Glenn Travis in Laboratory of Molecular Systematics, Smithsonian
Institution. Washington, DC 20560, and the protocols of Walsh and collaborators and
the one described by Morin and Woodruff in Paternity exclusion using multiple
hypervariable microsatellite loci amplified from nuclear DNA of hair cells. Pages 6381 of (Martin R.D. (Zürich) Dixson A.F. (Franceville) Wickings E.J. (Franceville).
1992). When genotypes were not clearly defined by the PCR, we troubleshooted this
by blindly testing the animals and then regenotyping them from the tissues. All
animals were fed on standard chow diet and water and were housed under 12h light:
12h darkness cycles.

4.4 Behavioral Testing
a. General Handling Procedures:
Animal handling was performed first. The animals were removed from home cages,
placed in clean clothes and handled approximately 30seconds each. All animals were
handled before individual tests in order to minimize handling-related stress. All
animals were acclimatized for at least 30minutes in the testing room before each test.
The behavioral tests were spaced by a week to minimize interference by previous
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procedures. Tests were administered in ascending order of novelty in order to reduce
carry over effects. All observational scoring was checked for inter-rater reliability.
The behavioral studies are described below in the order in which they were
conducted.

b. Functional Observational Battery:
The functional observational battery is a noninvasive method used to detect gross
functional deficits prior to more specific neurobehavioral evaluation. It is used to
comprehensively assess and quantify the behavioral and physiological state of the
mouse. Due to the visually observed deficits in ambulation, a functional observational
battery was developed from a published industry version (Irwin, 1968) for use with
this group of animals.

The body position, locomotor activity, bizarre behavior,

tremors, finger-withdrawal, touch escape, ataxic gait, and hypotonic gait are observed
and scored in these tests (Irwin. 1968).
First the animals were subjected to the least provoking stimuli which involved an
initial phase of undisturbed observation and a later manipulative phase. The
assessment in this phase and the undisturbed behavior i.e., body position, locomotor
activity, bizarre behavior, exophthalmos, respiration, tremors, twitches and
convulsions were assessed. The animals were then transferred and were briskly
dropped onto the floor of the viewing arena for testing the transfer arousal and spatial
locomotion. Observations were then made if tremors were present. Observations for
gait and limb rotation were also made. The categories measured included general
arousal, gait, reflexes, and motor behavior. Scoring of 0 to 8 range was used
throughout FOB, with values 0, 2, 4, 6, and 8 which represents none, slight, moderate,
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marked and extreme magnitudes of behavior. The scores were summed for each
category and then for over all categories (Irwin, 1968).

c. Open field test (OFT):
The locomotor activity and thigmotactic behavior can be evaluated using an open
field chamber in which infrared photo-beams (Hamilton Kinder, Motor Monitor
Version 3.11; Poway, CA, USA) are employed to measure locomotor activity in real
time. The open field arena has dimensions of 40 X 40 cm and is divided into central
(20X20 cm) and peripheral (10 cm wide) zones. The IR beams are interrupted by
movements and sorted into different measures based on algorithms in the Motor
Monitor Software (Lad et al. 2010; Tatem et al. 2014). Each mouse was placed in the
center of the open field arena under the red light and allowed to explore it for 10
minutes. Measurements such as horizontal beam interruptions, vertical beam
interruptions (rearing), distance traveled, time ambulating, spatial distribution of
behaviors, and fine movements (repeated activation of one horizontal beam only)
were measured. If mice spend more time in the area close to the wall then it is an
indicator of increased stress level, whereas if they explore the center of the arena then
it indicates that they can tolerate a mildly stressful environment. The open field arena
was cleaned with 70% ethanol solution and let dry after testing each mouse.

d. Elevated Plus Maze (EPM):
This is a behavioral paradigm that takes advantage of the conflict behavior of rodents
between exploration of a novel area and aversion to open and elevated spaces (Hata et
al. 2001). The expression of scores as percentage of time and distance in the open
arms allows for the correction of overall changes due to exploration of the maze,
reducing the activity-induced artifacts (Hogg. 1996).
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The device has the shape of a cross with each arm being of 5 X 35 cm. Two arms are
open and two of them have walls of 15 cm high, with the arms connected by a 5X5
cm central square. The arms are 76 cm above the floor.
Mice were tested on the plus maze in a room with low, indirect incandescent red
lighting and very low noise levels. The mouse was placed at the center of the maze
with head facing the open arm and allowed to explore for 5 minutes. The number of
entries into open and closed arms, as well as the time spent and distance travelled in
open and closed arms was recorded with the help of an automated EPM (Hamilton
Kinder, Version 3.11; Poway, CA). Animals sensitive to stressful environments avoid
the open arms of the maze. The mazes are cleaned with 70% ethanol and permitted to
dry between sessions. Automated software (Kinder Scientific Motor Monitor
Software Package, Built 08356-14) kept a record of the number of entries, distance
travelled (inches), and time spent (seconds) in the closed and open arms. Entry was
determined when all the four paws of the mouse were on the arm.

e. Y maze activity:
The Y-maze measures a mouse’s working memory status and exploits the innate
tendency to explore novel areas. The apparatus used for this test is an acrylic maze
with 3 arms at 120 degrees to each other, each arm 3.5 cm wide and 20 cm long. The
acclimatization period to the room was 1 hour. Then the animal is placed in the center
of the apparatus. The sequence of arm entries (entry defined as all four paws within
the arm), alternation sequence (entering three different arms in succession e.g. ABC
or BCA) are video recorded for 8 minutes for each sequence. The percentage of
alternation was determined by dividing the total number of alterations by the total
number of choices minus 2, multiplied by 100.
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f. Pre-pulse Inhibition (PPI):
This is a test to evaluate psychosis-like behavior. Mice were tested in automated
startle chambers (SM100 Startle Monitor System Version 6.12; Hamilton Kinder,
Poway, CA, USA) for PPI. They were calibrated prior to the day of testing. Mice
were placed in the startle chamber and allowed to acclimate for 5 min. A background
noise of 60 dB was on in between trials. The animals were then presented with 30
trials randomly mixed of startle stimuli (loud white noise) and pre-pulse stimuli
(lower dB white noise preceded by loud). The startle stimuli consist of a 20 ms white
noise stimulus presented at 2 different intensities (85 or 100 dB). The pre pulse
stimulus consists of 20ms, 70 dB white noise pulse, presented 100ms prior to the
startle (85 or 100 dB) stimulus (70dB + 100 ms + 85 dB and 70 dB + 100 dB). The
inter trial intervals range from 9-16 s. The startle response was recorded on a pressure
plate (Sharma, Elased, and Lucot, 2012).

g. Rotarod test:
The rotarod test is used to assess motor coordination by measuring the latency to fall
off the rotating drum. The rod is 3cm in diameter and designed so that the mouse only
drops 25cm onto a plate that stops a timer. The animals were moved to the experiment
room from their home cages 30 minutes prior to testing. There were two protocols
followed, one that used a constant speed (25rpm) for 2min and a second that used
accelerating speeds for 5min (up to 30rpm). Both tests were conducted with all
subjects. Learning sessions were conducted for 3 days in which the animals were
placed on a rotarod (24rpm) for a maximum of 60s and the latency to fall off was
recorded. The animals were then returned to their home cage for 5-10 minutes and
then the session was repeated for 3 times each day of training. For the learning
sessions (3 consecutive days): Each mouse was placed on a rotating rod (24 rpm) for a
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maximum of 60s and the latency to fall off was recorded. In test session, two trails
were conducted at a fixed speed with a maximum time of 60s, and an hour later the
animal was tested on an accelerating rod. The animal was placed on a rotating rod and
then the speed was increased every minute up to 44rpm for a maximum of 5 minutes.
The latency was recorded when the animal falls. The same test was performed again
10 minutes later. This procedure was adapted from Current Protocols in
Neuroscience, 2001 and Pallier, Drew, and Morton, 2008.

h. Forced Swim Test:
The Forced Swim Test (FST) is used to evaluate depression-like behavior. In this test,
mice were placed in a transparent glass cylinder (diameter 10 cm, height 35 cm)
which was filled up to 30 cm with water (23-25°C). The mice were tested separately
in different cylinders with an opaque white plexi glass separating them so that the
mice cannot see each other during the test. This testing is video recorded and scored
for durations of immobility. After the test the mice were dried with a towel and
returned to their home cage and placed on a thermal blanket heated to 37C. A mouse
was considered as immobile when floating motionless or making only those
movements necessary to keep its head above the water (Castagné et al., 2001; Sharma
et al., 2010).
Scoring
A new time-scoring technique was used to score several behaviors during a single
viewing session which has been shown to be both reliable and valid for detecting
antidepressant effects of both desipramine and fluoxetine in the FST (Detke et al.,
1995). The scoring had three different categories scored based on definitions,
“floating in the water without struggling and making only those movements necessary
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to keep the head above water” which is considered immobility; “making active
swimming motions, more than necessary to merely maintain the head above water”
(i.e., moving around in the cylinder) called swimming; “making active movements
with forepaws in and out of the water, usually directed against the walls” which is
climbing; and “having entire body submerged” called diving. In these tests, diving
occurred and was not reliably altered by the compounds tested, data for diving are not
reported. All of the behavior scoring was done by a single rater, who was unaware of
treatment condition. This new procedure to score many active behaviors in the FST
was used to re-evaluate the effects of different types of anti-depressant drugs (Detke,
Rickels, and Lucki, 1995). Selective norepinephrine (NE) uptake inhibitors, such as
desipramine and maprotiline, reduced immobility and selectively increased climbing
without affecting swimming. Previously effects of serotonin (5 hydroxytryptamine; 5HT) uptake inhibitors in the FST were considered as false negatives in this test, but
this scoring system revealed the effects of serotonin (5 hydroxytryptamine; 5-HT)
uptake inhibitors in the FST, such as fluoxetine, sertraline, and paroxetine also
reduced immobility but increased swimming instead of climbing. Thus, an analysis of
behavioral patterns in the FST distinguished drugs that have a common therapeutic
outcome and those that act on distinct neurotransmitter systems. To avoid these falsepositives, tail suspension test (TST) can be used to test the depressive-like behavior
which has different false positives. A literature search revealed monoaminergics (e.g.,
amphetamine, paroxetime)-induced decreases in immobility time which might be
false positives in the forced swim test (Zhao et al. 2008).

i. Tail Suspension Test:
Mice were suspended by their tails for 6 minutes (50 Can, Adem 2012). The subject’s
behavior was recorded with a video camera and scored afterwards. A suspension bar
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(1 cm. height, I cm. width, 60 cm. length) and tape (Time Med Labelling Systems,
Inc., Burr Ridge IL, 1.9 cm width were used. The mice were suspended by their tails
by attaching them to the suspension bar with tape in a way that they cannot escape or
hold on to nearby surfaces. The distance between mouse nose and floor was
approximately 20-25 cm. The mice were separated from each other using opaque
plastic to prevent interaction or observance between each other. A polycarbonate tray
was placed at the bottom of each mouse suspension to collect feces and urine.
Some strains of mice (mainly C57s) have a behavior called tail climbing and can thus
hold on to their tails during the test and negate it. We suspect that this strain of mouse
will have that response because their background strain is C57Bl/6. In order to
prevent this from happening a clear hollow cylinder approximately 4 cm long, 1.6 cm
outside diameter, 1.3 cm inside diameter, and weighing 1.5 grams made from
polycarbonate tubing was placed around the tails of the mice to prevent tail climbing
behavior of the mice.
The animals were brought to the testing room an hour before testing. The climb
stoppers were placed around the tail of the mouse and the tape was applied at the very
end of the tail leaving 2-3 mm outside the tape. The mouse was suspended by placing
the free end of the tape on the suspension bar. At the end of 6 minutes the animals
were returned to their cages and the tape was removed by gently pulling it off.

4.5 Brain dissection
Animals were sacrificed by decapitation. The brains were removed and the frontal
cortex was hand dissected. The remainder of the brain was placed in a brain matrix
(Ted Pella, Inc) and sliced into 1mm or 2 mm slabs rostral to the intraneural line,
(Caudate : 5-4, Amygdala/Hypothalamus: 3-2, Hippocampus: 2-1, Brain stem1: 1-0,
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Brain stem2: 0- -1) which were then stored at -80C on plastic squares until further
dissection. Amygdala and the caudate nucleus were dissected using landmarks in The
Mouse Brain Stereotaxic Coordinates (Paxinos and Franklin, 2008) as a guide.
Accumbens was taken using a tissue punch (-20̊ C ice blocks) of 1mm thickness.
Other sections were dissected using landmarks in The Mouse Brain Stereotaxic
Coordinates (2008) as a guide.

Figure 7 - Brain blocker – used to dissect the brain into 1 mm slabs.
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Figure 8 - Sagittal section of the mouse brain. The vertical line rostral to the
intraural line indicates the slots where razor blades were placed for dissection.

4.6 Neurochemical studies
a. Preparation of tissue samples
All the brain tissues were homogenized in 0.2N HCl using a homogenizer followed by
centrifugation. The supernatants were collected into 2 aliquots, which were stored at 80ºC until they were analyzed by HPLC.
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b. Determination of catecholamines by High Performance Liquid
Chromatography (HPLC)
HPLC is high performance liquid chromatography which is used to separate, identify
and quantify the components in a mixture. Its function relies on a high-pressure pump
which passes a pressurized liquid solvent containing the sample through a short,
narrow column which is filled with a solid adsorbent material. Each component of the
sample interacts differently with the adsorbent material causing different retention
times of each component which helps in separation as they flow through the column.
The electrochemical detector attached to the machine generates a signal proportional
to the amount of the sample component eluting from the column. Here we used BAS
LC-4B and BAS LC-4C detector with a potential of 0.75V and maintained across a
glossy carbon working electrode with a positive radial flow. This electrochemical
(amperometric) detector is attached to the system to identify the separated
components of the sample as they get eluted from the column. In this amperometric
cell the column effluent passes electrodes to which a voltage is applied. As the
molecules in the column effluent pass the electrodes they become oxidized when the
potential is sufficiently large.

The amount of current drawn to drive the

electrochemical reaction is quantified and concentration determined by reference to an
external standard.
The supernatant (sample) in the aliquot is injected directly into the chromatographic
system. Chromatographic separation was conducted using a BAS 100 X 3 mm C18
column (BAS model MF-8954), 80 X 4.6mm C18 column (ESA model 68-0100)
optimized to 0.75V. The mobile phase consisted of soap (1-octanesulfonic acid),
acetonitrile and dimethyl acetamide. The flow rate was kept at 0.3ml/min.
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c. Brain monoamine analysis
To identify monoamines, a series of standard solutions containing known amounts of
monoamines includingnorepinephrine (NE), 3,4 - dihydroxyphenylacetic acid
(DOPAC), 5-Hydroxy Indole acetic acid (5-HIAA), Homovanillic acid (HVA),
Dopamine (DA) and serotonin (5-HT) were injected into the chromatography system
before and after each sample analysis. The concentrations of mono amines in the
samples were determined by comparing the peak heights from the samples relative to
that of the standards. The concentrations of NE, DA, HVA, DOPAC, 5-HIAA and 5HT were expressed as ng/mg of wet tissue. The ratio between the metabolite and the
parent compounds (e.g. HVA/DA, DOPAC/DA, 5-HIAA/5-HT) was used as a
surrogate index of neurotransmitter usage.

4.7 Spot Urine Collection
Urine was collected from each animal by gently scruffing the animal and placed it on
clean surface until it urinated. The urine was collected using a pipette and placed in a
micro tube which was placed in ice until storage at -80 C until analysis. Subjects that
did not urinate after 30s were placed in a clean empty cage until they did.

4.8 Urine catecholamine extraction
Catecholamines in spotted urine were extracted over neutral alumina, activity grade 1,
from Sigma Chemical Co. product A-9003 supplemented with an internal standard
consisting of 2,3-dihydroxybenzoic acid (DHBA).This preliminary extraction over
alumina is necessary for down-stream electrochemical detection of urine
catecholamines. This procedure removes electroactive species in the urine that cannot
be separated by HPLC (Smith et al. 2013). Extraction was done as follows: alumina
was placed in 1.5mL tubes and supplemented with HCl containing sodium
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metabisulfite. To assay samples spot urine, DHBA internal standard and tris buffer
were added. The pH was then adjusted to 8.5±0.05 by adding Tris buffer. Then the
tube was vortexed, centrifuged and then the supernatants were removed and diluted
with deionized water. This was done for 2 times. Then the supernatants were removed
and further diluted with HClO4 containing sodium metabisulfite. The tube was then
vortexed; centrifuged and the supernatants were aliquoted into different 0.5 mL tubes
and stored at -80̊C until analysis (Smith et al. 2013).

4.9 Determination of catecholamines by High Performance Liquid
Chromatography (HPLC)
To determine catecholamines in these processed samples, 20µL of them were directly
injected into the chromatographic system. Chromatographic separation was conducted
using 80 X 4.6mm C18 column (ESA model 68-0100) optimized to 0.55V. The
mobile phase consisted of soap (1-octanesulfonic acid), methanol and acetonitrile.
The flow rate was kept at 0.3ml/min.

4.10 Adrenal isolation and preparation of the tissue sample
Animals were sacrificed by decapitation and then the adrenal glands were dissected,
weighed onto empty 1.5ml tubes and labelled with the animal identification number.
A single weighed adrenal gland was submerged in PBS buffer and DHBA stock (as an
internal standard) and homogenized in the buffer using a homogenizer keeping the
samples on ice in between homogenizing cycles. The homogenates were added to a
tube containing HCLO4 to be filtered and centrifuged at. Supernatants were then
collected into 3 aliquots and stored at -80C until HPLC analysis.
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5. Data Analysis
A DataQ device attached to the detector records the waveforms and using Windaq
software.
The data were analyzed by using STATISTICA data analysis software (Stat soft,
Tulsa, OK). The results are presented as group means±S.E.M. and analyzed using
STATISTICA data analysis software. Data were analyzed by 1-way ANOVA test. It
was used to evaluate the overall significance among groups. Tukey-HSD post hoc test
was used to identify individual group differences. We also used Kruskal Wallis one
way analysis of variance in the FOB and rotarod test.

6. Results
6.1 Behavioral tests
a. Functional Observational Battery
The NKCC2A-HO had significant differences in its walking behavior which is gait.
The HO mice group had higher scores compared to the HE and WT mice. As shown
in Fig.9, there were significant differences in the gait category (Fig 9) with NKCC2AHO having higher gait score compared to NKCC2A-HE and WT [factor ‘genotype’ F
(2, 28) = 3.524, p < 0.05 vs WT and HE].

b. Forced swim test
As shown in Fig.10, NKCC2A-HO mice were immobile for significantly less time
compared to WT and HE mice during the 6 minute forced swim test [factor
‘genotype’ F (2, 28) = 31.044, p < 0.001 vs WT and HE].
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c. Tail suspension test
As shown in Fig.11 there were no significant differences between mice of the three
genotypes during the 6 minute lasting tail suspension test [factor ‘genotype’, F (2, 22)
= 0.59, p >0.05 vs WT and HE].

d. Peripheral Rest time
As shown in Fig.12, during the 10 min of the test session in the open field NKCC2AHEmice spent significantly more time in the periphery than in the central zone [factor
‘genotype’ F (2, 28) = 5.7466, p < 0.05 vs WT and HO].

e. Rearing
Fig.13 shows a significant differences between NKCC2A-WT, NKCC2A-HE and
NKCC2A-HO mice in the rearing phenomena in the open field test [factor ‘genotype’
F (2, 28) = 4.03, p < 0.05].

6.2 Neurochemical Analysis
a. The caudate of NKCC-HO mice exhibit low 5-HIAA/5-HT ratios
The 5-HIAA/5-HT ratio in the caudate of NKCC2A-HO was significantly low (Fig.
14a, p<0.05) when compared to NKCC2A WT (Fig. 14a) [factor ‘genotype’ F (2, 28)
= 4.514, p < 0.05 vs WT].

b. The caudate of NKCC2A-HO mice exhibit low DOPAC/DA ratios
The DOPAC/DA ratio in the caudate of NKCC2A-HO was significantly low (Fig.
14b, p<0.05) when compared to NKCC2A-HE and WT (Fig. 14b) [factor ‘genotype’
F (2, 28) = 5.04, p < 0.05 vs WT and HE].
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c. The septum of NKCC2A-HE mice exhibit high DOPAC/DA ratios
The DOPAC/DA ratio in the septum of NKCC2A-HE mice was significantly higher
than that of NKCC2A-HO and WT mice (Fig. 14c, p<0.05). However, there were no
significant differences in individual neurotransmitter levels [factor ‘genotype’ F (2,
28) = 4.07, p < 0.05 vs WT and HO].

6.3 Urine
As shown in Fig 15a, 15b, 15c, there were no significant differences in urine NE, EPI
and DA levels between the mice of three genotypes.

6.4 Adrenals
There was a significant decrease in the NE (Fig 16a) levels in NKCC2A-HO mice
when compared to NKCC2A-HE and WT [factor ‘genotype’ F (2, 23) = 4.12, p <
0.05 vs WT].
There was a significant decrease in the EPI (Fig. 16b) levels in NKCC2A-HO mice
when compared to NKCC2A-HE and WT [factor ‘genotype’ F (2, 23) = 4.744, p <
0.05 vs WT].
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7. Results
7.1 Behavior Results

Figure 9 - Functional Observational Battery
Sum of the arousal category and the gait categories in WT, HE and HO. The HO
group had significantly higher gait scores [factor ‘genotype’ F (2, 28) = 3.524, p <
0.05 vs WT and HE].

Figure 10 - Forced swim test
Immobility time. Immobility of the HO group was lower compared to the WT and HE
[factor ‘genotype’ F (2, 28) = 31.044, p < 0.001 vs WT and HE].
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Figure 11 - Tail suspension test
Immobility time. No significant changes in the Immobility of the HO group compared
to the WT and HE [factor ‘genotype’, F (2, 22) = 0.59, p >0.05 vs WT and HE].

Figure 12 - Open field test – Peripheral resting time
Time (sec) spent resting in the periphery during a 10 min test. HE mice were
different from WT and HO mice. No other differences were significant [factor
‘genotype’ F (2, 28) = 5.7466, p < 0.05 vs WT and HO].
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Figure 13 - Open field test - Rearing
Total number of rearing events in the ten min test. The WT were lower than either
HE or HO [factor ‘genotype’ F (2, 28) = 4.03, p < 0.05].

7.2 Neurochemistry Results

Figure 14a - 5-HIAA/5-HT ratios in caudate
5-HIAA/5-HT ratios observed in the caudate area of WT, HE and HO mice [factor
‘genotype’ F (2, 28) = 4.514, p < 0.05 – significant difference from WT].
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Figure 14b - DOPAC/DA ratios in caudate
DOPAC/DA ratios in caudate area of WT, HE and HO mice [factor ‘genotype’ F (2,
28) = 5.04, p < 0.05 – significant difference from WT and HE].

Figure 14c - DOPAC/DA ratios in septum
DA usage levels in Septum area of WT, HE and HO mice [factor ‘genotype’ F (2, 28)
= 4.07, p < 0.05 – significant difference from WT and HO].
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7.3 Spot Urine Results

Figure 15a - Norepinephrine levels in spot urine

Figure 15b - Epinephrine levels in spot urine
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Figure 15c - Dopamine levels in spot urine

7.4 Adrenal Results

Figure 16a - Norepinephrine levels in adrenals
Norepinephrine levels observed in adrenals of WT, HE and HO mice [factor
‘genotype’ F (2, 23) = 4.12, p < 0.05 – significant difference from WT].
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Figure 16b - Epinephrine levels in adrenals
Epinephrine levels observed in adrenals of WT, HE and HO mice [factor ‘genotype’ F
(2, 23) = 4.744, p < 0.05 – significant difference from WT].
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Behavioral test

Result

Functional operational battery (FOB)

Increased gait in NKCC2-HO compared to the WT and HE

Open field test (OFT)

Higher rearing in NKCC2A-HO mice compared to the WT and
HE

Elevated plus maze (EPM)

No differences in anxiety across the three groups

Y maze test

No significant spontaneous alterations across the 3 groups

Prepulse inhibition (PPI)

No significant disruption in PPI

Rotarod

No differences in motor coordination and balance among the 3
groups

Forced swim test (FST)

Increased immobility time of the NKCC2A-HO mice compared to
the WT and HE

Tail suspension test (TST)

No significant change in immobility time of the NKCC2A-HO
mice compared to the WT and HE

Table 2 - Summary of Behavioral results

Accumb Amygdala

Brain stem

ens
NE
DOPAC

5-HIAA

HVA
DA
5-HT

Higher in HE
Higher in HE

Higher in HE
Lower
in HO
indeterm
inate

Hypothalam

Septum

us
indeterminate

Lower
in HO

Caudate

Higher in
Higher in HE
HE
Lower in
Higher in HE
HO
Lower in
HO
Higher in
HE

Higher in HVA
and HO

Lower in HO
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Lower in
HO

Higher in
HE

Higher in
Higher in HE
HE

Lower in
HO

DOPAC/DA
HVA/DA

Lower in
HO

5-HIAA/5-HT

Table 3 - Summary of Neurochemistry results
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Higher in
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8. Discussion
We performed a preliminary characterization of the behavioral and neurochemical
phenotypes of mice lacking a single (HE) or both (HO) alleles of NKCC2A and
compared the results against WT. The HE tissues exhibits intermediate level of
NKCC2A expression, whereas HO does not show any expression with high
expression levels in the WT indicating all the three groups have different levels of
NKCC2A expression and its effect might be different across the groups. Based on
anecdotal behavior observations noted in NKCC2A-HO mice, we evaluated them by
using a functional observational battery followed by specific behavioral tests
including open field test, y maze activity, elevated plus maze, pre-pulse inhibition,
rotarod test, forced swim test, and tail suspension test.
There were few visually observed deficits in ambulation of the NKCC2A- HO mice.
A functional observational battery developed from a published industry version
(Irwin, 1968) was used with this group of animals which measured the categories of
general arousal, gait, reflexes, and motor behavior. The pattern of movement of the
limbs during locomotion is gait and abnormal gait is observed in several neurological
and musculoskeletal disorders. There were significant differences in the gait category
with the NKCC2A-HO group having higher impairment but no significant differences
were observed in rotarod test which suggest that NKCC2A might be involved in areas
affecting gait rather than balance. Abnormality in gait generally indicate some gross
functional deficits in the CNS which were later assessed using specific behavioral
tests. Therefore, this suggests that the NKCC2 might affect the CNS in areas involved
in locomotor activity like walking.
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In FST, which is used to detect the anti-depressant like effect, the NKCC2A-HO mice
displayed significantly lower immobility time compared to the HE and the WT mice
(Fig 2) which was not reproduced by TST. Motor stimulants (Betin et al. 1982, De
Pablo et al. 1989) generally produce false positives in the FST (Panconi et al. 1993).
Nicotine (1mg/kg) has a weak but significant anti-depressant like effect consistent
with the excitatory substances which constitute false positives for the FST (Porsolt et
al. 1978) (Panconi et al. 1993). However, in this study, there were no significant
differences in the motor activity (basic movement and fine movement) of NKCC2AHO mice. Thus, the decrease in immobility time in FST in NKCC2A-HO was
independent of changes in locomotor activity suggesting that NKCC2A might have an
effect related to the swimming challenge in the FST rather than behavioral despair
challenge in the TST.
There might be the effect of thermogenesis in the FST that is producing decreased
immobility in NKCC2A-HO mice. Sympathetic nervous system and thyroid hormone
play a major role in generation and regulation of heat (Silva. 2006). Interestingly,
preliminary results from our laboratory indicate that NKCC2 mRNAs are expressed in
the thyroid at very low levels. Therefore, NKCC2A-HO mice might experience
hypothermia in FST condition leading to decreased immobile behavior which cannot
be observed in temperature-insensitive TST.
There were lower 5-HT and intraneural DA usage in the caudate nucleus which is
mainly associated with motor activity, suggesting its role in the FST effect. Caudate
nucleus receives projections from the A9 group of dopaminergic cell bodies which are
located in the substantia nigra (Feldman. 1997). The significant neurochemical change
in the caudate dopaminergic system was not supported by the results of the locomotor
activity in the open field test indicating that NKCC2A is not effecting the overall
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motor activity. But, there is a study showing significant elevation in prodynorphin
(pDyn) mRNA levels following FST in the caudate putamen but not in the nucleus
accumbens, hypothalamus, amygdala, frontal cortex or hippocampus indicating that
caudate might be solely involved in this process (Reed et al. 2012). No changes in the
DA and 5-HT usage in frontal cortex, amygdala, nucleus accumbens and
hypothalamus which are common areas involved in both FST and TST explain that
these areas might not be responsible for the immobile behavior in the tests. We
suggest that NKCC2A might have an effect on DA system in the caudate nucleus but
not in the other areas involved in motor activity.
In the open field test, there were no significant differences in locomotor activity
which measures the fine movements (usually grooming), distance traveled in total or
in zones or total time spent in either zone. The NKCC2A-HO exhibited a higher level
of rearing compared to the WT mice in the open field test which may relate to more
exploratory behavior in these mice. There was also a difference in the time spent
resting in the periphery exhibiting thigmotactic behavior. However, this has uncertain
significance in the absence of any difference in total time in the periphery, distance
traveled in the periphery or any measurement in the central zone.
The elevated plus maze revealed no significant differences among groups in the time
spent either in the open arm or in the closed arm. This is usually interpreted as a lack
of difference in their ability to tolerate a stressful environment. This test is strongly
responsive to benzodiazepine type anti-anxiety treatments and not to other classes of
anxiolytics. No significant differences among the groups suggest that the GABA and
benzodiazepine receptors are functionally normal which generally effect anxiety and
performance in the elevated plus maze.
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Y maze testing revealed no differences among mice of the three genotypes. Frontal
cortex is the anatomical site for working memory and dopamine neurotransmission in
the frontal cortex plays a major role in y-maze testing. The working memory was not
different across the three groups. This observation is consistent with absence of
significant changes in the DA usage in frontal cortex.
We used prepulse inhibition (PPI) of startle to evaluate genotype dependent effect on
psychosis-like symptoms in NKCC2A-HO mice. There were no significant
differences among groups in PPI of startle which measures the inhibitory response to
a loud white noise stimulus (85 or 100 dB) when it is immediately preceded by a
softer (70 dB) white noise. This is a basic circuit present in all normal species but
deficient in schizophrenics. It is used as a screen for antipsychotic drugs by measuring
their ability to reverse impairment of the PPI produced by either a dopamine
antagonist or dopaminergic neurotransmission in frontal cortex (Zavitsanou et al.
1999) or phencyclidine (Yee et al. 2004; Bakshi and Geyer. 1997). There was no
disruption in the PPI behavior which indicates absence of psychosis-like symptoms in
the NKCC2A-HO mice and also indicating that NKCC2A-HO did not affect the
hearing or sound perception. Interestingly, NKCC2 is expressed in the endolymphatic
sac (Nishimura et al. 2009). Together, these results suggest the possibility that either
NKCC2B or NKCC2F are expressed in ES or that NKCC2A has a minimal if any role
in audition. Dopaminergic neurotransmission in the frontal cortex plays a major role
in the modulation of startle reflex measured by PPI (Zavitsanou et al. 1999; Yee et al.
2004; Bakshi and Geyer. 1997; Mehler-Wex et al. 2006). Absence of changes in PPI
correlates with the insignificant changes in the frontal cortex and amygdala dopamine
usage suggesting that NKCC2A is not affecting the dopamine projections innervating
these areas.
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There was a significant decrease in the adrenal NE and EPI levels in the NKCC2AHO mice compared to the wild type and heterozygous mice (Fig 16A, 16B).
SLC12A1 gene was found to be expressed in supraoptic and paraventricular neurons
of the hypothalamo-neurohypophyseal system during salt load condition. The
interactions among the hypothalamus, pituitary and adrenal gland forms the major
part of the neuroendocrine system that controls stress related reactions. Expression of
NKCC2 in the hypothalamo-neurohypopheseal system, a specialized brain region
involved in the elaboration of peptide hormones that directly control the kidney
function explains both the central and peripheral role of NKCC2 in the crucial
mechanisms to regulate salt and water balance. In the kidney NKCC2 is regulated by
arginine vasopressin (AVP). AVP released from an endocrine source or
paracrine/autocrine source might provoke NKCC2 synthesis and activity (Konopacka
et al. 2015). Thus we speculate that the NKCC2A-HO mice which had low NE and
EPI adrenal levels but not significantly lower urinary catecholamine levels,
compromise their ability to respond to the sympathetic stimulation.
Further studies
There is preliminary evidence of the presence of NKCC2A in some sections of the
brain such as the frontal cortex, somatosensory cortex and in the cerebral cortex. Its
expression was much higher in the WT mice compared to the HE mice and with no
expression in the HO mice (unpublished observation). We did not perform tests to
evaluate learning and cognitive behavior, there can be further investigations focused
on the attention and cognitive abnormalities of the NKCC2A-HO mice as well as
studies related to these brain areas showing NKCC2A expression, to determine the
effect of its presence in these areas and to pursue the FST and TST discrepancy which
is an interesting finding. Because of greater variability in urinary catecholamine
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levels, we could not conclude there was a significant effect of NKCC2A on
sympathetic activity. High salt-loaded rats were observed to have elevated NKCC2
expression (Haque et al. 2011), therefore there is a need to look at the urinary
catecholamine levels in stress (salt-load) induced mice. Further studies can be focused
on stress induced urinary catecholamine levels to see the effect of NKCC2A and also
with a greater ‘N’ to increase the statistical significance of the study.
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